List of works - Jean-Frédéric Colombel

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

scientific article (publication date: 31 May 2001)

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

scientific article (publication date: 4 May 2002)

Infliximab for induction and maintenance therapy for ulcerative colitis

scientific article

Infliximab, azathioprine, or combination therapy for Crohn's disease

article

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

scientific article

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

scientific article

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

scientific article

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

scientific journal article

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

scientific article published on 15 January 2010

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

scientific article

Vedolizumab as induction and maintenance therapy for Crohn's disease

scientific article

Vedolizumab as induction and maintenance therapy for ulcerative colitis

scientific article

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

scientific article published on November 4, 2011

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease

scientific article published on March 2002

Mapping of a susceptibility locus for Crohn's disease on chromosome 16

scientific article

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

scientific article published on 03 October 2012

Risk factors for opportunistic infections in patients with inflammatory bowel disease

scientific article

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

scientific article

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

scientific article published on 30 April 2007

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

scientific article published in November 2009

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

scientific article

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

scientific article published on 03 October 2012

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

scientific article published on 25 August 2015

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease

scientific article published on 01 December 1998

Dysbiosis in inflammatory bowel disease

scientific article

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

scientific article published on 10 December 2006

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials

scientific article

The natural history of adult Crohn's disease in population-based cohorts

scientific article published on 27 October 2009

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

scientific article published on June 2, 2013

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

scientific article published on 06 March 2014

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease

scientific article published on 24 May 2007

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

scientific article (publication date: 17 November 2016)

Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis

scientific article published on June 14, 2013

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

scientific article published on 01 June 2000

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

scientific article

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

scientific article published on February 8, 2012

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

scientific article published on 01 February 2004

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

scientific article published on June 1, 1998

Geographical variability and environmental risk factors in inflammatory bowel disease

scientific article published on 18 January 2013

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

scientific article published on May 21, 2014

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

scientific article

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

scientific article published on 01 April 2001

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

scientific article published on 28 July 2016

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

scientific article

Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death

scientific article published on September 2001

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

scientific article

Clinical implications of mucosal healing for the management of IBD.

scientific article published on December 2009

European evidence-based Consensus on the management of ulcerative colitis: Current management

scientific article

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

scientific article

Natural history of pediatric Crohn's disease: a population-based cohort study

scientific article published on 3 July 2008

List of works by Jean-Frédéric Colombel

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Infliximab for induction and maintenance therapy for ulcerative colitis

Infliximab, azathioprine, or combination therapy for Crohn's disease

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

Vedolizumab as induction and maintenance therapy for Crohn's disease

Vedolizumab as induction and maintenance therapy for ulcerative colitis

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease

Mapping of a susceptibility locus for Crohn's disease on chromosome 16

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

Risk factors for opportunistic infections in patients with inflammatory bowel disease

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease

Dysbiosis in inflammatory bowel disease

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials

The natural history of adult Crohn's disease in population-based cohorts

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

Geographical variability and environmental risk factors in inflammatory bowel disease

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

Clinical implications of mucosal healing for the management of IBD.

European evidence-based Consensus on the management of ulcerative colitis: Current management

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

Natural history of pediatric Crohn's disease: a population-based cohort study